Real-Time AI Monitoring & Early Detection of Immune-Related Adverse Events

May 02, 2024 12:00 p.m. - 1:00 p.m. ET

To register to attend, you must log in to your SITC Cancer Immunotherapy CONNECT account. Don’t have an account? Create a free one.

Join Dr. Mullin of the Roswell Park Comprehensive Cancer Center and Dr. Bao of the UPMC Hillman Cancer Center as they talk about artificial intelligence’s (AI’s) role in real-time monitoring of patients who are receiving immunotherapy for immune-related adverse events (irAE).

If you attend, you’ll learn about:

  • the current application of AI in irAE monitoring and detection.
  • future applications of these technologies across the field.

This webinar is the first of the 2024 SITC-NCI Computational Immuno-oncology Webinar Series, which focuses on the application of AI in immuno-oncology. It consists of nine free webinars to help individual research labs overcome computational challenges while analyzing and integrating different assay data throughout the immuno-oncology spectrum using AI. The annual series aims to educate early-career scientists, increase participants’ awareness of and engagement in NCI-supported Cancer Moonshot℠ Immunotherapy Networks, and fulfill the Blue Ribbon Panel’s goal of accelerating progress in cancer research.

Sarah Mullin, Ph.D., M.S.

Dr. Mullin serves as an assistant professor of oncology at Roswell Park Comprehensive Cancer Center.

Riyue Bao, Ph.D.

Dr. Bao is the co-director of bioinformatics at UPMC Hillman Cancer Center.

Vote below about this page’s helpfulness.

Enter the characters shown in the image.